|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.58 SEK | -0.65% |
|
+14.79% | +186.25% |
| 04-19 | Pila Pharma Appoints New CEO, Chief Scientific Officer | MT |
| 04-19 | Pila Pharma AB Announces Board and Management Appointments | CI |
Pila Pharma AB (publ) reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was SEK 0.535 million. Net loss was SEK 10.34 million compared to SEK 2.46 million a year ago.
Basic loss per share from continuing operations was SEK 0.64 compared to SEK 0.24 a year ago. Diluted loss per share from continuing operations was SEK 0.64 compared to SEK 0.24 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +186.25% | 10.43M | |
| +54.47% | 815B | |
| +44.25% | 654B | |
| -6.41% | 354B | |
| +21.65% | 337B | |
| +10.72% | 302B | |
| +18.45% | 247B | |
| +2.09% | 229B | |
| +13.03% | 219B | |
| +8.69% | 171B |
PILA PHARMA AB 
